Liu Tong, Hu Kebang, Zhao Zuowei, Chen Guanglei, Ou Xunyan, Zhang Hao, Zhang Xin, Wei Xiaofei, Wang Dan, Cui Meizi, Liu Caigang
Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China 150000.
Department of Urology, First Hospital of Jilin University, Changchun, China 130021.
Oncotarget. 2015 Dec 8;6(39):41638-49. doi: 10.18632/oncotarget.5873.
We investigated the miRNA profiles of breast cancer stem cells (CSCs) and non-CSC tumor cells by miRNA microarray and determined the effect of altered miR-1 expression on proliferation and migration of breast CSCs. The potential targets of miR-1 in the Wnt/β-catenin signaling were characterized by bioinformatics analysis and luciferase assay. We found that 14 miRNAs were up-regulated and 13 were down-regulated in the ESA+CD44+CD24-lineage- CSCs, related to ESA+CD44-CD24+lineage- non-CSC tumor cells. The miR-1 expression was associated inversely with aggressiveness of breast cancers. Furthermore, enhanced miR-1 expression decreased the percentages of SKBR3/CSCs and miR-1 inhibition increased the percentages of MCF-7/CSCs. Enhanced miR-1 expression significantly reduced the Frizzled 7 and Tankyrase-2 (TNKS2)-regulated luciferase activity in 293T cells and decreased Frizzled 7, TNKS2, c-Myc, octamer-binding transcription factor 4 (Oct4) and Nanog expression and the ratios of nuclear to cytoplasmic β-catenin as well as β-catenin-dependent luciferase activity in breast CSCs in vitro. miR-1 inhibited proliferation, migration and wound healing of breast CSCs in vitro. Enhanced miR-1 expression inhibited the growth of implanted MCF-7/CSCs while miR-1 inhibition promoted the growth of implanted MCF-7/CSCs in vivo. Our data indicate that miR-1 down-regulates breast CSC stemness, proliferation and migration by targeting the Frizzled 7 and TNKS2 to inhibit the Wnt/β-catenin signaling.
我们通过miRNA微阵列研究了乳腺癌干细胞(CSCs)和非CSC肿瘤细胞的miRNA谱,并确定了miR-1表达改变对乳腺癌CSCs增殖和迁移的影响。通过生物信息学分析和荧光素酶测定对Wnt/β-连环蛋白信号通路中miR-1的潜在靶点进行了表征。我们发现,与ESA+CD44-CD24+谱系的非CSC肿瘤细胞相比,ESA+CD44+CD24-谱系的CSCs中有14种miRNA上调,13种miRNA下调。miR-1表达与乳腺癌的侵袭性呈负相关。此外,增强miR-1表达可降低SKBR3/CSCs的比例,而抑制miR-1则可增加MCF-7/CSCs的比例。增强miR-1表达可显著降低293T细胞中由卷曲蛋白7(Frizzled 7)和端粒酶2(TNKS2)调节的荧光素酶活性,并降低体外培养的乳腺癌CSCs中Frizzled 7、TNKS2、c-Myc、八聚体结合转录因子4(Oct4)和Nanog的表达以及核/质β-连环蛋白的比例以及β-连环蛋白依赖性荧光素酶活性。miR-1在体外抑制乳腺癌CSCs的增殖、迁移和伤口愈合。增强miR-1表达可抑制植入的MCF-7/CSCs的生长,而抑制miR-1则可促进植入的MCF-7/CSCs在体内的生长。我们的数据表明,miR-1通过靶向Frizzled 7和TNKS2抑制Wnt/β-连环蛋白信号通路,从而下调乳腺癌CSCs的干性、增殖和迁移能力。